Plant viral nanoparticles-based HER2 vaccine: Immune response influenced by differential transport, localization and cellular interactions of particulate carriers.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Biomaterials

• Publication date

  2017-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.biomaterials.2016.12.030PMID 28063980
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Emerging nanotechnologies for cancer immunotherapy

  2016cited by this paper
• Virus-based nanoparticles as platform technologies for modern vaccines.

  2016influential reference
• Synthetic Nanoparticles for Vaccines and Immunotherapy.

  2015cited by this paper
• Plant Virus Particles Carrying Tumour Antigen Activate TLR7 and Induce High Levels of Protective Antibody

  2015cited by this paper
• Toxicities of Immunotherapy for the Practitioner.

  2015cited by this paper
• Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy

  2015cited by this paper
• Tropism of CPMV to Professional Antigen Presenting Cells Enables a Platform to Eliminate Chronic Infections.

  2015cited by this paper
• Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy.

  2015cited by this paper
• Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors

  2015cited by this paper
• Rapid and Persistent Delivery of Antigen by Lymph Node Targeting PRINT Nanoparticle Vaccine Carrier To Promote Humoral Immunity.

  2015cited by this paper
• NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy

  2015cited by this paper
• Immunoengineering: how nanotechnology can enhance cancer immunotherapy.

  2015cited by this paper
• In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer

  2015cited by this paper
• The Impact of Aspect Ratio on the Biodistribution and Tumor Homing of Rigid Soft‐Matter Nanorods

  2015cited by this paper
• Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling*

  2015cited by this paper
• Stealth filaments: Polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X.

  2015cited by this paper
• Therapeutic vaccines for cancer: an overview of clinical trials

  2014cited by this paper
• Future of cancer vaccines.

  2014influential reference
• The role of Fc gamma receptors in the activity of immunomodulatory antibodies for cancer

  2014cited by this paper
• Biodistribution and clearance of a filamentous plant virus in healthy and tumor-bearing mice.

  2014influential reference
• Presentation of HER2 epitopes using a filamentous plant virus-based vaccination platform.

  2014cited by this paper
• Differential Uptake of Nanoparticles and Microparticles by Pulmonary APC Subsets Induces Discrete Immunological Imprints

  2013cited by this paper
• Engineering synthetic vaccines using cues from natural immunity.

  2013cited by this paper
• Peripherally Administered Nanoparticles Target Monocytic Myeloid Cells, Secondary Lymphoid Organs and Tumors in Mice

  2013cited by this paper
• Cancer immunotherapies, their safety and toxicity

  2013cited by this paper
• Cancer vaccines: always a bridesmaid, never a bride?

  2013influential reference
• Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle Potato virus X.

  2013cited by this paper
• Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung.

  2013cited by this paper
• Convective diffusion of nanoparticles from the epithelial barrier toward regional lymph nodes.

  2013cited by this paper
• Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy.

  2012cited by this paper
• Viral nanoparticles for in vivo tumor imaging.

  2012cited by this paper
• Particle-mediated delivery of cytokines for immunotherapy.

  2012cited by this paper
• Blockade of the HER family of receptors in the treatment of HER2-positive metastatic breast cancer.

  2012cited by this paper
• Control of size dispersity of chitosan biopolymer microparticles and nanoparticles to influence vaccine trafficking and cell uptake.

  2012cited by this paper
• Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients

  2012cited by this paper
• The effect of nanoparticle size, shape, and surface chemistry on biological systems.

  2012cited by this paper
• The art of engineering viral nanoparticles.

  2011cited by this paper
• Improvement of different vaccine delivery systems for cancer therapy

  2011cited by this paper
• Cancer Immunotherapy and Nanomedicine

  2011cited by this paper
• Applications of viral nanoparticles in medicine.

  2011cited by this paper
• Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells.

  2011cited by this paper
• Nanoparticle Delivery Systems in Cancer Vaccines

  2011cited by this paper
• In Vivo Modulation of Dendritic Cells by Engineered Materials: Towards New Cancer Vaccines.

  2011cited by this paper
• Induction of Endoplasmic Reticulum–Endosome Fusion for Antigen Cross-Presentation Induced by Poly (γ-Glutamic Acid) Nanoparticles

  2011cited by this paper
• Immunogenic properties of chimeric potato virus X particles displaying the hepatitis C virus hypervariable region I peptide R9.

  2010cited by this paper
• Anti-HER2 vaccines: new prospects for breast cancer therapy

  2010cited by this paper
• Dendritic Cell-Specific Antigen Delivery by Coronavirus Vaccine Vectors Induces Long-Lasting Protective Antiviral and Antitumor Immunity

  2010cited by this paper
• Strategies in the design of nanoparticles for therapeutic applications

  2010cited by this paper
• B cell follicles and antigen encounters of the third kind

  2010cited by this paper
• Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns

  2010cited by this paper
• Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies.

  2010cited by this paper
• Viral nanoparticles and virus‐like particles: platforms for contemporary vaccine design

  2010cited by this paper
• A Protease-Dependent Mechanism for Initiating T-Dependent B Cell Responses to Large Particulate Antigens

  2010cited by this paper
• Viral nanoparticles as platforms for next-generation therapeutics and imaging devices.

  2010cited by this paper
• The who, how and where of antigen presentation to B cells

  2009cited by this paper
• Plant-produced potato virus X chimeric particles displaying an influenza virus-derived peptide activate specific CD8+ T cells in mice.

  2009cited by this paper
• Endothelial Targeting of Cowpea Mosaic Virus (CPMV) via Surface Vimentin

  2009cited by this paper
• Interaction of Cowpea Mosaic Virus (CPMV) Nanoparticles with Antigen Presenting Cells In Vitro and In Vivo

  2009cited by this paper
• Multipeptide vaccination in cancer patients

  2009influential reference
• The microanatomy of B cell activation.

  2009cited by this paper
• Fcgamma receptors as regulators of immune responses.

  2008cited by this paper
• Virus-sized vaccine delivery systems.

  2008cited by this paper
• Lentivector immunization induces tumor antigen‐specific B and T cell responses in vivo

  2008cited by this paper
• Fcγ receptors as regulators of immune responses

  2008cited by this paper
• Nanoparticles target distinct dendritic cell populations according to their size

  2008cited by this paper
• Innate immune response induced by gene delivery vectors.

  2008cited by this paper
• Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice

  2007cited by this paper
• Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics

  2007cited by this paper
• B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node.

  2007cited by this paper
• Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer

  2007cited by this paper
• In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles.

  2006cited by this paper
• Virus-Like Particles as Carriers for T-Cell Epitopes: Limited Inhibition of T-Cell Priming by Carrier-Specific Antibodies

  2005cited by this paper
• Conformational HER-2/neu B-cell Epitope Peptide Vaccine Designed to Incorporate Two Native Disulfide Bonds Enhances Tumor Cell Binding and Antitumor Activities*

  2005cited by this paper
• Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy

  2004cited by this paper
• Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

  2003cited by this paper
• A Chimeric Multi-Human Epidermal Growth Factor Receptor-2 B Cell Epitope Peptide Vaccine Mediates Superior Antitumor Responses1

  2003influential reference
• Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her‐2/neu

  2003cited by this paper
• Virus-like particles as immunogens.

  2003cited by this paper
• Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

  2002cited by this paper
• Danger signals: SOS to the immune system.

  2001cited by this paper
• Chimeric Plant Virus Particles as Immunogens for Inducing Murine and Human Immune Responses against Human Immunodeficiency Virus Type 1

  2001cited by this paper
• Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccines.

  2001cited by this paper
• The HER-2/neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy.

  1998cited by this paper
• Biodistribution and tumor localization of stealth liposomal tumor necrosis factor‐α in soft tissue sarcoma bearing rats

  1998cited by this paper
• Biodistribution and tumor localization of stealth liposomal tumor necrosis factor-alpha in soft tissue sarcoma bearing rats.

  1998cited by this paper
• The HER‐2/neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy

  1998cited by this paper
• Tolerance, danger, and the extended family.

  1994cited by this paper
• Depot characteristics and biodistribution of interleukin-2 liposomes: importance of route of administration.

  1992cited by this paper
• Two proteins from cowpea mosaic virus.

  1971cited by this paper

• Plant Viral Vectors for Vaccine Development

  2026cites this paper
• Virus nanoparticle intratumoral vaccines for HER2+ malignancies

  2025cites this paper
• Immunofunctions of Protein and Carbohydrate Assemblies Modulated by Structures Acrossing Scales as Biomaterials.

  2025cites this paper
• Recent advances in immunotherapy for breast cancer

  2025cites this paper
• Challenges and opportunities on achieving an adequate delivery efficiency and immunogenicity with peptide-based anticancer vaccines.

  2025cites this paper
• An overview of the use of nanoparticles in vaccine development

  2025cites this paper
• Development of a pod pepper vein yellows virus-based expression vector for the production of heterologous protein or virus like particles in Nicotiana benthamiana

  2025cites this paper
• A cowpea mosaic virus adjuvant conjugated to liposomes loaded with tumor cell lysates as an ovarian cancer vaccine

  2025cites this paper
• Transformation of a Viral Capsid from Nanocages to Nanotubes and Then to Hydrogels: Redirected Self-Assembly and Effects on Immunogenicity.

  2024cites this paper
• Plant-Derived Anti-Cancer Therapeutics and Biopharmaceuticals

  2024cites this paper
• Plant Virus Intratumoral Immunotherapy with CPMV and PVX Elicits Durable Antitumor Immunity in a Mouse Model of Diffuse Large B-Cell Lymphoma.

  2024cites this paper
• Assessment of a Structurally Modified Alternanthera Mosaic Plant Virus as a Delivery System for Sarcoma Cells

  2024cites this paper
• Transcutaneous Immunization of 1D Rod-Like Tobacco-Mosaic-Virus-Based Peptide Vaccine via Tip-Loaded Dissolving Microneedles.

  2024cites this paper
• Tailoring biomaterials for vaccine delivery

  2024cites this paper
• Biomaterial engineering strategies for B cell immunity modulations

  2024cites this paper
• Self-assembled nanoparticles: A new platform for revolutionizing therapeutic cancer vaccines

  2023cites this paper
• TLR Agonists Delivered by Plant Virus and Bacteriophage Nanoparticles for Cancer Immunotherapy.

  2023cites this paper
• Plant Virus Nanoparticles Combat Cancer

  2023cites this paper
• Vaccine adjuvants: mechanisms and platforms

  2023cites this paper
• The Potency of Cowpea Mosaic Virus Particles for Cancer In Situ Vaccination Is Unaffected by the Specific Encapsidated Viral RNA.

  2023cites this paper
• Plant-derived nanoparticles and plant virus nanoparticles: Bioactivity, health management, and delivery potential

  2023cites this paper
• Immunotherapy for HER-2 positive breast cancer

  2023cites this paper
• A co-formulated vaccine of irradiated cancer cells and cowpea mosaic virus improves ovarian cancer rejection.

  2023cites this paper
• Development of a Modular NTA:His Tag Viral Vaccine for Co-delivery of Antigen and Adjuvant.

  2023cites this paper
• Injectable Slow-Release Hydrogel Formulation of a Plant Virus-Based COVID-19 Vaccine Candidate

  2022cites this paper
• Multifunctional plant virus nanoparticles: An emerging strategy for therapy of cancer.

  2022cites this paper
• Instigation of the epoch of nanovaccines in cancer immunotherapy.

  2022cites this paper
• Protein Informatics and Vaccine Development: Cancer Case Study.

  2022cites this paper
• Multifunctional Plant Virus Nanoparticles for Targeting Breast Cancer Tumors

  2022cites this paper
• Biomaterial-enhanced cancer vaccines

  2022cites this paper
• Emerging Potential of Plant Virus Nanoparticles (PVNPs) in Anticancer Immunotherapies

  2022cites this paper
• Injectable Hydrogel Containing Cowpea Mosaic Virus Nanoparticles Prevents Colon Cancer Growth.

  2022cites this paper
• Emerging vaccine nanotechnology: From defense against infection to sniping cancer

  2022cites this paper
• S100A9‐Targeted Cowpea Mosaic Virus as a Prophylactic and Therapeutic Immunotherapy against Metastatic Breast Cancer and Melanoma

  2021cites this paper
• Alfalfa mosaic virus nanoparticles-based in situ vaccination induces antitumor immune responses in breast cancer model.

  2021cites this paper
• A Scalable Manufacturing Approach to Single Dose Vaccination against HPV

  2021cites this paper
• The pharmacology of plant virus nanoparticles.

  2021cites this paper
• The Versatile Manipulations of Self-Assembled Proteins in Vaccine Design

  2021influential citation
• A biotin-avidin-system-based virus-mimicking nanovaccine for tumor immunotherapy.

  2021cites this paper
• Preclinical models and technologies to advance nanovaccine development.

  2021cites this paper
• Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy.

  2021cites this paper
• Plant-based vaccines and cancer therapy: Where are we now and where are we going?

  2021cites this paper
• Multifunctional biomolecule nanostructures for cancer therapy

  2021cites this paper
• Non-spherical micro- and nanoparticles for drug delivery: Progress over 15 years.

  2021cites this paper
• Designing S100A9-Targeted Plant Virus Nanoparticles to Target Deep Vein Thrombosis.

  2021cites this paper
• Development of a Virus-Like Particle-Based Anti-HER2 Breast Cancer Vaccine

  2021influential citation
• Vaccine delivery systems toward lymph nodes

  2021cites this paper
• Multifunctional plant virus nanoparticles in the next generation of cancer immunotherapies.

  2021cites this paper
• Trivalent Subunit Vaccine Candidates for COVID-19 and Their Delivery Devices

  2021cites this paper
• Emerging nanomaterials for cancer immunotherapy

  2021cites this paper
• Nanoparticulate systems and their translation potential for breast cancer therapeutics

  2021cites this paper
• Mannose-binding lectin and complement mediate follicular localization and enhanced immunogenicity of diverse protein nanoparticle immunogens

  2021cites this paper
• Cowpea Mosaic Virus Nanoparticle Vaccine Candidates Displaying Peptide Epitopes Can Neutralize the Severe Acute Respiratory Syndrome Coronavirus

  2021cites this paper
• Protein-based nanomaterials and nanosystems for biomedical applications: A review

  2020cites this paper
• Virus‐Like Nanoparticle‐Mediated Delivery of Cancer Therapeutics

  2020cites this paper
• Enhancing Immunity with Nanomedicine: Employing Nanoparticles to Harness the Immune System.

  2020cites this paper
• The Role of Virus-Like Particles in Medical Biotechnology.

  2020cites this paper
• Cowpea Mosaic Virus (CPMV)-Based Cancer Testis Antigen NY-ESO-1 Vaccine Elicits an Antigen-Specific Cytotoxic T Cell Response.

  2020cites this paper
• Advances of functional nanomaterials for cancer immunotherapeutic applications.

  2020cites this paper
• Rational Design of Antigen Incorporation Into Subunit Vaccine Biomaterials Can Enhance Antigen-Specific Immune Responses

  2020cites this paper
• Controlling timing and location in vaccines

  2020cites this paper
• Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications

  2020cites this paper
• Affinity of plant viral nanoparticle potato virus X (PVX) towards malignant B cells enables cancer drug delivery.

  2020cites this paper
• Leveraging the Modularity of Biomaterial Carriers to Tune Immune Responses

  2020cites this paper
• Emerging Concepts and Technologies in Vaccine Development

  2020cites this paper
• The sixth revolution in pediatric vaccinology: immunoengineering and delivery systems

  2020cites this paper
• Plant virus particles with various shapes as potential adjuvants

  2020cites this paper
• Protein cages and virus-like particles: from fundamental insight to biomimetic therapeutics.

  2020cites this paper
• Improving Cancer Immunotherapy Outcomes using Biomaterials.

  2020cites this paper
• Plant viral nanoparticles for packaging and in vivo delivery of bioactive cargos.

  2020cites this paper
• Biomedical Applications of Viral Nanoparticles in Vaccine Therapy

  2020cites this paper
• Antibody Response against Cowpea Mosaic Viral Nanoparticles Improves In Situ Vaccine Efficacy in Ovarian Cancer.

  2020cites this paper
• PDL1-targeted vaccine exhibits potent antitumor activity by simultaneously blocking PD1/PDL1 pathway and activating PDL1-specific immune responses.

  2020cites this paper
• Cowpea Mosaic Virus Promotes Anti‐Tumor Activity and Immune Memory in a Mouse Ovarian Tumor Model

  2019cites this paper
• Small, Smaller, Nano: New Applications for Potato Virus X in Nanotechnology

  2019cites this paper
• Presentation and Delivery of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand via Elongated Plant Viral Nanoparticle Enhances Antitumor Efficacy.

  2019cites this paper
• Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers

  2019cites this paper
• Protein-based nanoparticles in cancer vaccine development.

  2019cites this paper
• The role of plant expression platforms in biopharmaceutical development: possibilities for the future

  2019cites this paper
• Cancer biologics made in plants.

  2019cites this paper
• Virus-derived materials: bury the hatchet with old foes.

  2019cites this paper
• Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy

  2019cites this paper
• Syntheses and functional studies of self-adjuvanting anti-HER2 cancer vaccines.

  2019cites this paper
• Plant Virus-Based Nanotechnologies

  2019cites this paper
• Future of cancer immunotherapy using plant virus-based nanoparticles

  2019cites this paper
• Biomimetic Nanotechnology toward Personalized Vaccines

  2019cites this paper
• Emerging Trends in the Development of Plant Virus-Based Nanoparticles and Their Biomedical Applications

  2019cites this paper
• Protein and Peptide Biomaterials for Engineered Subunit Vaccines and Immunotherapeutic Applications.

  2019cites this paper
• Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine.

  2019cites this paper
• A Viral Nanoparticle Cancer Vaccine Delays Tumor Progression and Prolongs Survival in a HER2+ Tumor Mouse Model

  2019cites this paper
• Virus-like antigen display for cancer vaccine development, what is the potential?

  2018cites this paper
• Delivery of mitoxantrone using a plant virus-based nanoparticle for the treatment of glioblastomas.

  2018cites this paper
• Green Nanoparticles : Biogenerators ; Mechanistic Aspects of Biosynthesis ; Potential Applications and Future Prospective

  2018cites this paper
• Plants as sources of natural and recombinant anti-cancer agents.

  2018cites this paper
• Repurposing Plant Virus Nanoparticles

  2018cites this paper
• Development and physicochemical, toxicity and immunogenicity assessments of recombinant hepatitis B surface antigen (rHBsAg) entrapped in chitosan and mannosylated chitosan nanoparticles: as a novel vaccine delivery system and adjuvant

  2018cites this paper
• Plant virus nanoparticles: Novel and robust nanocarriers for drug delivery and imaging.

  2018cites this paper
• Chemical addressability of potato virus X for its applications in bio/nanotechnology.

  2017cites this paper
• Reconceptualizing cancer immunotherapy based on plant production systems

  2017cites this paper